Dr. Cecelia Yates Receives the Emerging Innovator Award from the University of Pittsburgh


Congratulations to Dr. Cecelia Yates for receiving the Emerging Innovator Award from the University of Pittsburgh Innovation Institute. The Innovation Institute established the Emerging Innovator Award in recognition of the potential difference developers can make on people’s lives through commercial translation. The Emerging Innovator Award was established three years ago to recognize Pitt innovators in mid-career who have demonstrated an extraordinary commitment to achieving impact for their research through commercialization.

Dr. Yates is an Associate Professor in the Department of Health Promotion & Development, School of Nursing at the University of Pittsburgh, with secondary appointments in the Department of Pathology, School of Medicine, and the Department of Bioengineering, School of Engineering.  Additionally, she is co-director of the University of Pittsburgh’s Clinical and Translational Science Institute’s TL1 Predoctoral Fellowship sponsored by NIH Clinical and Translational Science Awards (CTSA) Program. Dr. Yates attended Tuskegee University, Tuskegee, Alabama, where she earned her BS in Biology/Chemistry and her PhD in Integrative Biomedical Science and Pathology in conjunction with the University of Pittsburgh. Upon completing her education, she participated in a Fellowship in Pathology at Pitt’s School of Medicine.

She is the co-founder and Chief Scientific Officer of Fibrokine Inc., a Pittsburgh-based start-up developing a broad spectrum of anti‐fibrotic chemokine peptides to treat organ fibrosis. She is also the co-founder and member of the Scientific Advisory Board of a Pittsburgh-based start-up, Ocugenix, focused on ocular therapeutic development. In addition, she is involved with several ongoing therapeutic commercialization ventures.

Dr. Yates has over 15 years of experience in fibroblast, chemokine, and extracellular matrix biology and the pathogenesis of organ fibrosis. She has a continuous track record of innovative research and therapeutic development in the field of tissue repair. Her research focuses are on understanding immune cell and stromal cell mediated interactions that contribute to the pathogenesis of fibrotic diseases such as systemic sclerosis (Scleroderma) and IPF. Her research group combines both translational and clinical models to develop therapeutics including biometric peptides, cellular transplantation, and bioreactive scaffolds to promote tissue regeneration. Dr. Yates’ research has been supported externally by the National Institute of Nursing Research, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and internally by the Chancellor’s Innovation Award, the Center for Medical Innovation, and the University of Pittsburgh Genomic Hub. Dr. Yates’ entrepreneurial activities include more than eight issued US patents, several international patents, and pending applications associated with her work.

Dr. Yates received the 2011 ASIP Excellence in Science Award and serves on the ASIP Council in the role of Councilor At-large. She is a member of a number of ASIP Committees, including the Research and Science Policy Committee and the Membership Committee. Dr. Yates serves as a member of the Editorial Board for The American Journal of Pathology

Congratulations, Dr. Yates!

Women in Pathology Leadership Development Event!

Deb Elbaum

Confident leadership requires time and self-reflection about one’s current strengths, as well as areas for development. Putting energy and intention toward developing these areas can help us not only build our authentic leadership presence and voice, but also result in greater interpersonal effectiveness and impact. In this interactive 1-hour workshop with Leadership Coach Deb Elbaum, attendees will get clearer about their current leadership skills and identify where they can put attention to be even more successful in their current or future role.

Deb Elbaum is an executive and leadership development coach who has been guiding people to think and act calmly and confidently for more than 15 years. She builds her clients’ capacity to manage challenges more effectively – including navigating change, building teams, creating strategic plans, communicating successfully, and inspiring and engaging others. Deb’s approach to coaching combines neuroscience, leadership models, and measurable action planning. She equips her clients for success by building their internal awareness and strategy toolkit so that they can quickly increase their external impact, interpersonal effectiveness, and authentic leadership presence.

A former physician and founder of a healthcare writing company, Deb partners with senior and emerging leaders in academia, healthcare, biotech, and pharma. Examples of clients include MIT, Tufts University, St. Jude Children’s Research Hospital, Massachusetts General Hospital, Takeda, Sanofi, and Karyopharm Therapeutics. Deb is known for her positive energy and ability to carefully listen, quickly reframe, and hone in on the heart of the matter. Her clients learn how to identify blindspots that are holding them back, cultivate their authentic leadership, and shift behaviors so they feel more purposeful, balanced, and productive.

Do you have an interest in growing your professional development and advocating on behalf of the biological and biomedical sciences?

In December 2019, the FASEB Board of Directors approved the addition of three new positions on the Board and three new positions on the Science Policy Committee for early-career researchers (ECRs). The inaugural three ECRs began their terms in July 2020. Subsequent ECR positions on the FASEB Board of Directors and Science Policy Committee will continue to be filled in a staggered manner in the years to come. Candidates interested in being considered should begin the process by inquiring with their scientific society regarding the timeline and nomination instructions.

Do you have an interest in growing your professional development and advocating on behalf of the biological and biomedical sciences?

If so, consider applying for an Early-Career Representative position on the FASEB Board of Directors or Science Policy Committee.
In addition to having a passion for advocating for the biological and biomedical sciences, nominees should be effective communicators across multiple stakeholders such as the member society and the general public; show a demonstrated commitment to serve science through scientific organizations; and hold a record of professional service, including active membership in The American Society for Investigative Pathology.

Nominations are due by
Monday, April 5.
Visit FASEB for more information and contact us to apply.

  • Early-career researchers make up a significant portion of the biological and biomedical sciences community, and the FASEB Board seeks their unique insights and opinions.
  • The Early-Career Representative positions are critical to the FASEB leadership and help foster dialogue between current and future generations of biological and biomedical researchers.
  • Early-Career Representative positions enable researchers to enhance their professional development and contribute to FASEB’s decision-making.

ASIP Members who were nominated and selected last year:

2020 recipient of the Fred Sanfilippo-ASIP Visiting Lectureship

Onur Kanisicak, PhD

Congratulations to Dr. Onur Kanisicak who is the recipient of the 2020 Fred Sanfilippo-ASIP Visiting Lectureship. Dr. Kanisicak is an Assistant Professor in the Department of Pathology and Laboratory Medicine in the College of Medicine at the University of Cincinnati.

The Fred Sanfilippo-ASIP Visiting Lectureship Program provides funding for ASIP members who are in the early stages of their academic careers to travel and visit other departments/institutions to give one or more research presentations as a distinguished visiting lecturer. The primary goal of this program is to provide exposure of promising young faculty to members of the greater pathobiology research community, increasing their national recognition and reputation. Fred Sanfilippo-ASIP Visiting Lecturers benefit from national exposure and interactions with faculty at the host institution which may result in new collaborations that will advance research endeavors at both institutions and may generate other beneficial long-term relationships such as distance mentoring within their chosen field of study.

Dr. Kanisicak’s laboratory studies how tissue homeostasis is supported by resident cell types that are not traditionally considered part of the parenchyma: fibroblasts, endothelial cells, and stem cells. His research group has developed unique genetically-modified mouse models to interrogate these cells, including reporter lines that permit in vivo tracing of fibroblast activation and proliferation, as well as mouse models that allow for temporal-specific ablation of fibroblast as they transition from quiescence to activated states. Their work to date has revealed that fibroblasts, previously thought to occupy only a structural role in muscle tissue, are actually among the first responders to tissue damage and play a central role in tissue regeneration by providing crosstalk with the other cells of the tissue.

Dr. Kanisicak will utilize his Fred Sanfilippo-ASIP Visiting Lectureship to travel to Baylor College of Medicine to deliver lectures in the Department of Molecular Physiology and Biophysics and the Cardiovascular Research Institute.

ASIP members at academic institutions who are in the early stages of their career (Assistant Professors and/or Associate Professors who have not yet been granted tenure), are eligible for the Sanfilippo-ASIP Visiting Lectureship Program. Competitive nominees must have an established and productive research record and generally be a few years past their initial academic appointment. A nomination for the Fred Sanfilippo-ASIP Visiting Lectureship program can be initiated by the individual researcher, their department chair, or the host department chair. Required elements of nomination packages can be found here. For more information on this program or to initiate a nomination, please contact wbcoleman@asip.org.

About Dr. Fred Sanfilippo

 Alfred P. (Fred) Sanfilippo, MD, PhD, is currently Professor of Pathology and Laboratory Medicine in the Emory University School of Medicine, Professor of Health Policy and Management in the Emory University Rollins School of Public Health, the Director of the Emory-Georgia Tech Healthcare Innovation Program, and Medical Director of the Marcus Foundation. Dr. Sanfilippo previously served Emory University as Executive Vice President for Health Affairs, Chief Executive Officer of the Robert W. Woodruff Health Science Center, and Chair of the Board of Directors for Emory Healthcare. In his earlier career, Dr. Sanfilippo served as a faculty member at Duke University (where he became Professor of Pathology, Experimental Surgery, and Immunology), Johns Hopkins University (where he served as Chair of the Department of Pathology), and The Ohio State University (where he served as Dean of the College of Medicine and Public Health, Senior Vice President and Executive Dean for Health Sciences, and CEO of the OSU Medical Center). Dr. Sanfilippo’s well-funded research programs have focused on the immunopathology of allograft rejection, receiving >$30M in funding and resulting in 3 patents, >225 original articles, 54 reviews, and 35 book chapters published to date. Dr. Sanfilippo served the ASIP from 1993-2003 as a representative to FASEB, 1996-2004 as a member of the ASIP Council, and as ASIP President in 2002-2003.

About the Fred Sanfilippo-ASIP Visiting Lectureship Program

When was the last time you upgraded your skill set?

A new opportunity for ASIP members brought to you from the
Committee for Career Development and Diversity and the Education Committee

Mentorship is important in every field, and even more so for scientists from underrepresented groups. The National Academies has released the latest in a series of podcasts with leading scientists about the role of mentorship in their careers. Listen to UCSF Vice Chancellor for Science Policy and Strategy and Research!America board member Dr. Keith Yamamoto, and theoretical physicist Dr. Jim Gates, reflect on their experiences here. To learn more about the Science of Effective Mentorship in STEMM report, and for a guide to implementing best practices at your institution, visit NAS.edu/mentoring